More importantly this show that Europe look at CE Mark (which was a major concern) to use the medical device, there's no doubt the 1st US clinical trial was stuff up by management but the 2nd US clinical trial were 33% of the time the 2 respiratory doctors at one of the most prodigious hospital couldn't even agree indicate how subjective respiratory disease diagnosis will always be if ResAppDx isn't used.
More importantly this show that Europe look at CE Mark (which...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #